An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis

Boel De Paepe, Ken R. Bracke, Jan L. De Bleecker

Open source

DOI
10.1016/j.cytox.2022.100063
Published
2022-03
Container
Cytokine: X
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cytox.2022.100063,
  title = {An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis},
  author = {Boel De Paepe and Ken R. Bracke and Jan L. De Bleecker},
  year = {2022},
  journal = {Cytokine: X},
  doi = {10.1016/j.cytox.2022.100063},
  url = {https://doi.org/10.1016/j.cytox.2022.100063}
}

RIS

TY  - JOUR
TI  - An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
AU  - Boel De Paepe
AU  - Ken R. Bracke
AU  - Jan L. De Bleecker
PY  - 2022
JO  - Cytokine: X
DO  - 10.1016/j.cytox.2022.100063
UR  - https://doi.org/10.1016/j.cytox.2022.100063
ER  - 

APA

Paepe, B. D., Bracke, K. R., & Bleecker, J. L. D. (2022). An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis. Cytokine: X. https://doi.org/10.1016/j.cytox.2022.100063

Source records